Creating value in challenging markets

During our last financial year, progress against our strategic objectives included:

• Took full ownership of De Novo Genetics, previously a joint venture with De-Su Holsteins, to enhance control over dairy product development
• Expanded our range of polled Holsteins, so that ABS now offers 23 of the industry’s top 29 homozygous sires
• Continued to increase genetic improvement in our beef nucleus herds and produced our first Wagyu and Nelore bulls
• Began offering Y-skewed sexed semen to help customers produce more male offspring and strengthen beef-on-dairy programmes
• Initiated pioneering Life Cycle Assessments for beef, to show how our elite genetics reduce an animal’s carbon footprint, and secured UK and US grants to continue developing ‘Climate Smart’ genetics

• Introduced the ABS VAP to enhance business effectiveness and improve operating profit
• Integrated IntelliGen into ABS and established a unified supply chain, increasing productivity and efficiency
• Transitioned most UK artificial insemination customers onto three- to five-year contracts, ensuring our service business is more predictable and profitable

• Accelerated adoption of our GENEadvance app, which uses artificial intelligence to analyse herd data and recommend improvements, to strengthen partnerships and increase revenue with more than 1,000 customers
• Established a further pull-through arrangement in Spain, as we continue to increase beef volumes and revenues across EMEA
• Conducted further product performance trials in five countries to demonstrate the superior performance of NuEra beef genetics in customer systems